ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Kodak loan to enter drug business is put on hold

by Michael McCoy
August 14, 2020 | APPEARED IN VOLUME 98, ISSUE 31

 

A US development bank has halted plans to lend money to Eastman Kodak after allegations of financial wrongdoing. Kodak wants to use the $765 million loan to enter the pharmaceutical chemical business and help the US boost domestic production of critical drugs. But Kodak’s stock price suspiciously jumped about 25% the day before the loan was announced. It was later disclosed that company executives received stock options around the time it began talks with the US. Kodak says it has hired an outside law firm to conduct a review.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment